Drug-resistant tuberculosis

From IDWiki
Revision as of 17:58, 18 November 2022 by Aidan (talk | contribs)

Classification

  • Multidrug resistant tuberculosis (MDR-TB): resistance to isoniazid and rifampicin
  • Extensively drug-resistant tuberculosis (XDR-TB): resistance to at least isoniazid and rifampicin, and to any fluoroquinolone, and to any of the three second-line injectables
  • Totally drug-resistant tuberculosis (TDR-TB): not well-defined

Management

  • 8 months of an intensive four-drug regimen that includes any four drugs to which it is susceptible, in order of preference:
    • Any first-line agents to which it is still susceptible
    • A fluoroquinolone (except ciprofloxacin)
    • An injectable: kanamycin, or other parenteral agent
    • Other second-line agents, starting with ethionamide
  • Followed by 12 months of a less intensive regimen (at least three effective drugs), for a total of at least 20 months
Resistance To Drug to Stop Drug to Add Regimen Total Duration
INH INH FQN 6 months RMP+EMB+PZA+FQN 6 months from date FQN started
INH INH FQN 2 months RMP+EMB+PZA+FQN then 4 months RMP+EMB+FQN 6 months from date FQN started
RMP RMP FQN 2 months daily INH+EMB+PZA+FQN then 10-16 months INH+EMB+FQN 18 months from date FQN started
RMP RMP None 2 months INH+EMB+PZA, then 16 months INH+EMB 18 months from date FQN started
EMB EMB None 2 months INH+RMP+PZA, then 4 months INH+RMP 6 months from start of therapy
PZA PZA None 2 months INH+RMP+EMB, then 7 months INH+RMP 9 months from start of therapy
INH+EMB INH+EMB FQN 6 months daily RMP+PZA+FQN 6 months from date FQN started
INH+PZA INH+PZA FQN 9 months RMP+EMB+FQN 9 months from date FQN started
INH+EMB+PZA INH+EMB+PZA FQN+injectable 2 months TMP+FQN+injectable, then 7 months RMP+FQN 9 months from date FQN started

References

  1. ^  Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis, Ilaria Motta, Nargiza Parpieva, Zinaida Tigay, Varvara Solodovnikova, Irina Liverko, Ronelle Moodliar, Matthew Dodd, Nosipho Ngubane, Mohammed Rassool, Timothy D. McHugh, Melvin Spigelman, David A.J. Moore, Koert Ritmeijer, Philipp du Cros, Katherine Fielding. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis. New England Journal of Medicine. 2022;387(25):2331-2343. doi:10.1056/nejmoa2117166.